Clinical Trials Directory

Trials / Terminated

TerminatedNCT01360918

Concomitant Epicardial Pulmonary Vein Isolation in Patients With Atrial Fibrillation Undergoing Elective Cardiac Surgery

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Medisch Spectrum Twente · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Recent studies demonstrated that radiofrequency isolation of the pulmonary veins (PVI) is a superior alternative to antiarrhythmic drug therapy in patients with symptomatical paroxysmal atrial fibrillation (AF). A substantial proportion of patients undergoing elective cardiac surgery also suffer from atrial fibrillation. No evidence exists if epicardial PVI is beneficial in patients with a history of AF undergoing coronary bypass surgery (CABG) for the concomitant treatment of AF. The investigators aim to establish the effectiveness of incorporating epicardial pulmonary vein isolation into elective cardiac surgery.

Conditions

Interventions

TypeNameDescription
DEVICEEpicardial pulmonary vein isolationAfter the CABG procedure, a bilateral epicardial pulmonary vein isolation is performed under general anaesthesia and double-lumen endotracheal ventilation.
OTHERUsual careManagement of atrial fibrillation according to current guidelines using rate control pharmacological therapy.

Timeline

Start date
2011-05-01
Primary completion
2013-05-01
Completion
2014-05-01
First posted
2011-05-26
Last updated
2016-07-07

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01360918. Inclusion in this directory is not an endorsement.